Disparities in Ovarian Cancer Clinical Trial Access Linked to Social Vulnerability: A U.S. County-Level Analysis
Introduction
Clinical trials are the cornerstone of advancing therapeutic options for ovarian cancer, a disease with a high mortality rate and often late diagnosis. However, equitable access to interventional clinical trials remains a persistent challenge, potentially exacerbating disparities in outcomes. This article reviews a comprehensive U.S. county-level study assessing how community social vulnerability influences availability of ovarian cancer clinical trials over a 13-year period.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.